Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
DLK1
100%
Endocrine Resistance
100%
Tumor-associated Macrophages
100%
Programmed Death Ligand
100%
Estrogen
50%
Tumor Cells
50%
Luminal Breast Cancer
50%
Mouse Model
33%
Overcoming Resistance
33%
Preclinical Animal Models
33%
Patient-derived Explants
33%
Singh
16%
Tumor-associated
16%
Combination Therapy
16%
Tumor Growth
16%
Cancer Stem Cells
16%
Immune Cells
16%
Stem Cell Activation
16%
Triple Therapy
16%
Notch Signaling
16%
Endocrine Therapy
16%
Tumor Microenvironment
16%
Acquired Resistance
16%
Additional Treatment
16%
CCR3
16%
Programmed Death-ligand 1 (PD-L1)
16%
CCL7
16%
M2-like
16%
Fulvestrant
16%
Immunosuppressive Microenvironment
16%
Luminal Tumors
16%
M2 Type
16%
Neuroendocrine-immune System
16%
Medicine and Dentistry
Neoplasm
100%
Breast Cancer
100%
Macrophage
100%
Immunosuppressive Drug
80%
Tumor Cell
60%
Tamoxifen
60%
Combination Therapy
40%
Tumor Microenvironment
40%
Immunotherapy
20%
Tumor Progression
20%
Hormone Therapy
20%
Cancer Stem Cell
20%
Immunocompetent Cell
20%
Cell Activity
20%
Notch Signaling
20%
Programmed Death-Ligand 1
20%
Fulvestrant
20%
Immunology and Microbiology
Tumor-Associated Macrophage
100%
Mouse Model
80%
Immunosuppressive Drug
80%
Tumor Cell
60%
Explant
40%
Immunotherapy
20%
Immunocompetent Cell
20%
Cancer Stem Cell
20%
Cell Activity
20%
Notch Signaling
20%
Programmed Death-Ligand 1
20%
CCL7
20%
Biochemistry, Genetics and Molecular Biology
Tumor-Associated Macrophage
100%
Mouse Model
80%
Explant
40%
Immunocompetent Cell
20%
Tumor Progression
20%
Cancer Stem Cell
20%
Notch Signaling Pathway
20%
Cell Activity
20%
CCL7
20%
PD-L1
20%
Fulvestrant
20%